External validation of novel clinical likelihood models to predict obstructive coronary artery disease and prognosis

Laust Dupont Rasmussen1,2, Michelle Claire Williams3, David E Newby3

  • 1Department of Cardiology, Gødstrup Hospital, Herning, Denmark lausra@rm.dk.

Open Heart
|December 6, 2023
PubMed

Insights

New clinical likelihood models, risk factor-weighted (RF-CL) and coronary artery calcium score-weighted (CACS-CL), better identify patients with very low risk of obstructive coronary artery disease (CAD). These models offer improved categorization with favorable long-term prognosis.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Risk Stratification

Background:

  • Obstructive coronary artery disease (CAD) diagnosis relies on accurate risk stratification.
  • Existing models like the European Society of Cardiology pretest probability (ESC-PTP) require external validation for novel approaches.
  • Risk factor-weighted clinical likelihood (RF-CL) and coronary artery calcium score-weighted clinical likelihood (CACS-CL) models aim to improve CAD risk assessment.

Purpose of the Study:

  • To externally validate the RF-CL and CACS-CL models for identifying obstructive CAD and guiding revascularisation decisions.
  • To compare the performance of RF-CL and CACS-CL against the ESC-PTP model.
  • To investigate the long-term prognosis of patients categorized into very-low clinical likelihood groups.

Main Methods:

  • A cohort of 1585 stable chest pain patients undergoing coronary CT angiography (CTA) was analyzed.
  • Obstructive CAD was defined as >70% diameter stenosis on CTA.
  • Clinical likelihood scores (ESC-PTP, RF-CL, CACS-CL) were calculated, and revascularisation decisions were recorded. Patient outcomes were followed for 5 years.

Main Results:

  • Both RF-CL and CACS-CL models classified significantly more patients into the very-low clinical likelihood (<5%) group compared to ESC-PTP (52.2% and 41.4% vs. 19.2%, p<0.001).
  • In the very-low likelihood group, prevalences of obstructive CAD (≤6%) and revascularisation (<1%) were low.
  • This low-risk group demonstrated a favorable prognosis with a low rate of non-fatal myocardial infarction or cardiovascular death over 5 years.

Conclusions:

  • The RF-CL and CACS-CL models provide improved categorization of patients with suspected obstructive CAD into a very-low risk group.
  • These novel models demonstrate preserved accuracy in identifying obstructive CAD and revascularisation needs within the low-risk stratum.
  • The validated models indicate a favorable long-term prognosis for patients classified as very-low risk, supporting their clinical utility.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...